Clinical Trial Update: Study of GS-0151 in Participants With Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

Update on a Phase 1 clinical trial of GS-0151 in rheumatoid arthritis. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• GS-0151

Snippet

Sponsor: Gilead Sciences | Conditions: Rheumatoid Arthritis | Phase 1 | Status: RECRUITING